General

Codagenix raises $20 million for a new flu vaccine and other therapies

Codagenix raises $20 million for a new flu vaccine and other therapies

Coadagenix, a company developing vaccines and viral therapies for illnesses ranging from the flu and respiratory viruses to dengue fever has raised $20 million in a new round of financing.
The company’s new investment round was led by Adjuvant Capital with a…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *